Skip to main content
. Author manuscript; available in PMC: 2014 Nov 14.
Published in final edited form as: J Mol Biomark Diagn. 2014 Nov 14;4(3):151. doi: 10.4172/2155-9929.1000151

Figure 4.

Figure 4

A case of recurrence after vaccination with phenotypic change in HER-2/neu expression. Immunohistochemical staining for tissue HER-2/neu (HercepTest). While the primary DCIS was HER2/neu positive, the emerged “recurred” tumor after vaccination from patient #10 was HER2/neu negative.